Advertisement

ASCO 2022: Using ctDNA to Guide Adjuvant Chemotherapy in Colon Cancer
Posted: 06/04/2022 | By: Chase Doyle

Question 1 of 5

In the randomized DYNAMIC trial, circulating tumor DNA (ctDNA) analysis was successful in what percentage of patients with stage II colon cancer?

Choose 1